Education
About Us
Working with TipRanks
Follow Us
FFTY - ETF AI Analysis
Top Page
Innovator IBD 50 ETF (FFTY)
Rating:70Outperform
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered solid gains so far this year and over the past month, showing positive recent momentum.
Leading Growth-Oriented Holdings
Several of the top positions, including major technology, mining, and industrial names, have shown strong year-to-date performance that supports the fund’s returns.
Sector Diversification Across Cyclical Areas
Holdings spread across materials, technology, health care, and industrials help the fund tap into multiple growth themes rather than relying on a single industry.
Negative Factors
High Expense Ratio
The fund’s expense ratio is relatively high for an ETF, which can eat into long-term returns compared with lower-cost alternatives.
Concentrated in a Few Sectors
A large share of assets is in materials, technology, and health care, so a downturn in these areas could hurt the fund more than a broadly diversified ETF.
Primarily U.S.-Focused
With most of its holdings in U.S. companies and only a small allocation to Canada, the fund offers limited geographic diversification.
FFTY vs. SPDR S&P 500 ETF (SPY)
AUM97.42M
RegionNorth America
Expense Ratio0.80%
Beta1.42
IssuerInnovator
Inception DateApr 09, 2015
Dividend Yield1.19%
Asset ClassEquity
Index TrackedIBD 50 TR
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume93,273
30 Day Avg. Volume100,203
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
45.57Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering50
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
FFTY Summary
The Innovator IBD 50 ETF (FFTY) is a fund that follows the IBD 50 Index, which picks 50 fast-growing stocks in the U.S. and Canada. It focuses on companies with strong sales and earnings trends, often smaller firms with big growth potential. The fund holds a mix of sectors, with a lot in materials, technology, and health care. Well-known names in the ETF include Micron and Kinross Gold. Someone might invest in FFTY to seek higher growth than the overall market, but it is concentrated in a small number of growth stocks, so its price can rise and fall sharply.
How much will it cost me?The Innovator IBD 50 ETF (FFTY) has an expense ratio of 0.8%, which means you’ll pay $8 per year for every $1,000 invested. This is higher than average because it’s actively managed, focusing on selecting top-performing growth stocks rather than passively tracking a broad index.
What would affect this ETF?The Innovator IBD 50 ETF (FFTY), with its focus on growth stocks and heavy exposure to technology and healthcare sectors, could benefit from advancements in innovation, favorable economic conditions, and increased investor interest in high-growth industries. However, it may face challenges from rising interest rates, regulatory changes, or economic slowdowns, which could negatively impact smaller-cap stocks and growth-focused companies. Its U.S.-centric portfolio also makes it sensitive to domestic market trends and policies.
FFTY Top 10 Holdings
FFTY is leaning hard into U.S.-listed growth names with a twist: it’s surprisingly heavy on materials, especially gold and mining plays like Coeur, Orla, and IAMGOLD, which have been rising over the past few months and now act as key engines for the fund. On the growth side, Micron and Vertiv are riding the AI and data-center wave, giving the ETF a tech-powered tailwind. Offsetting some of that strength, AnaptysBio and FTAI Aviation look more mixed, with shaky fundamentals that can occasionally tug on performance rather than push it forward.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Coeur Mining | 3.59% | $3.26M | $15.26B | 323.53% | 69 Neutral | |
| IAMGOLD | 3.57% | $3.25M | $13.23B | 302.47% | 73 Outperform | |
| Comfort Systems | 3.51% | $3.19M | $48.93B | 310.23% | 80 Outperform | |
| AnaptysBio | 3.51% | $3.19M | $1.46B | 261.49% | 49 Neutral | |
| Stoke Therapeutics | 3.49% | $3.17M | $1.93B | 321.81% | 70 Outperform | |
| Kinross Gold | 3.44% | $3.12M | $40.59B | 196.94% | 81 Outperform | |
| Applied Optoelectronics | 3.43% | $3.12M | $7.50B | 451.49% | 52 Neutral | |
| Vertiv Holdings | 3.42% | $3.10M | $93.52B | 185.90% | 77 Outperform | |
| Anglogold Ashanti PLC | 3.38% | $3.07M | $58.02B | 261.58% | 73 Outperform | |
| Sterling Infrastructure | 3.34% | $3.04M | $12.73B | 226.61% | 71 Outperform |
FFTY Technical Analysis
Positive
―
Price Trends
37.54
Positive
37.19
Positive
35.40
Positive
Market Momentum
0.81
Negative
52.80
Neutral
55.21
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FFTY, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 38.60, equal to the 50-day MA of 37.54, and equal to the 200-day MA of 35.40, indicating a bullish trend. The MACD of 0.81 indicates Negative momentum. The RSI at 52.80 is Neutral, neither overbought nor oversold. The STOCH value of 55.21 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FFTY.
FFTY Peer Comparison
Comparison Results
Performance Comparison
FFTY
Innovator IBD 50 ETF
39.26
12.55
46.99%
BAMD
Brookstone Dividend Stock ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
BUZZ
VanEck Social Sentiment ETF
―
―
―
TMFE
Motley Fool Capital Efficiency 100 Index ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents